Autopsy report · NCT02830763
Clinical Study on the Safety of CNT-02 for TGCV and NLSD-M
Cause of deathNo reason given
Life of this trial
- Registered 2 months before it started.
- Ran for about 2 years 4 months before it stopped.
- 2 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
- Sponsor type
- University, hospital or other
- Conditions
- Primary Triglyceride Deposit Cardiomyovasculopathy (TGCV); Neutral Lipid Storage Disease With Myopathy (NLSD-M)
- Interventions
- CNT-02
- Participants
- 2
- Sites
- 7
- Countries
- Italy, Japan
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.